Drug Trial Radar · NCT07839884
A Continuation Study of Tilrekimig in Adults With Moderate-to-Severe Long-Term Breathing Difficulty, Known by the Medical Term of Chronic Obstructive Pulmonary Disease (COPD) to Learn About This Medicine When Used for a Long Period of Time
Last checked: Nov 19, 2026Latest source record: Nov 18, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
1,360
Planned (sponsor's estimate)
Start
Oct 14, 2026
Primary completion
Apr 21, 2034
Study completion Apr 21, 2034
Sponsor
- Lead sponsor
- PfizerPfizer (PFE)
- Sponsor type
- Industry
- First posted
- Sep 24, 2026
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 35 years, up to 80 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
A Continuation Study of Tilrekimig in Adults with Moderate-to-Severe Long-Term Breathing Difficulty, Known by the Medical Term of Chronic Obstructive Pulmonary Disease (COPD) to Learn About this Medicine when Used for a Long Period of Time.
Conditions
- Moderate to Severe Chronic Obstructive Pulmonary Disease
Interventions
TilrekimigDrug
SC injection
Primary outcomes
What the sponsor says the trial is designed to measure.
- Number of Participants With Treatment-Emergent Adverse Events During Treatment Period 1 (TP1)Time frame: Up to 60 weeks
- Number of Participants With Treatment-Emergent Serious Adverse Events During Treatment Period 1Time frame: Up to 60 weeks
- Number of Participants With Treatment-Emergent Adverse Events Leading to Permanent Discontinuation of Study Intervention During Treatment Period 1Time frame: Up to 60 weeks
- Number of Participants With Clinically Significant Laboratory Abnormalities During Treatment Period 1Time frame: Up to 60 weeks
Locations
3 sites in 1 country. Site status is shown where the registry gives one.
Institute of HealthCare Assessment d/b/a Apex Clinical Research
San Diego, California · Recruiting
Southeastern Research Center
Winston-Salem, North Carolina · Recruiting
Clinical Research Associates of Central PA
DuBois, Pennsylvania · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.